Table 4.
Baseline to follow-up changes in medication status.
| Parameters | Participants, n | Baseline value | Follow-up value | Difference | t test (df) | McNemar χ2 (df) | 95% CI | P value | |||||||||
| Total sample | |||||||||||||||||
|
|
Average number of hypertension medications | 117 | 1.1 | 1.2 | 0.1 | 1.1 (116) | N/Aa | –0.05 to 0.17 | .28 | ||||||||
|
|
Adherent to medications (Simplified Medication Adherence Questionnaire), % | 90b | 36.7 | 51.1 | 14.4 | N/A | 5.8 (90) | N/A | .02 | ||||||||
| Stage 2 subsample | |||||||||||||||||
|
|
Average number of hypertension medications | 77 | 1.0 | 1.2 | 0.2 | 2.2 (76) | N/A | 0.01 to 0.30 | .03 | ||||||||
|
|
Adherent to medications (Simplified Medication Adherence Questionnaire), % | 54b | 35.2 | 46.3 | 11.1 | N/A | 2.0 (54) | N/A | .16 | ||||||||
aN/A: not applicable.
bAmong participants taking ≥1 hypertension medications at baseline.